Impact of pulsed field ablation on intraluminal esophageal temperature
Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural s...
Saved in:
Published in | Journal of cardiovascular electrophysiology Vol. 35; no. 1; pp. 78 - 85 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.
Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA
DS
Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe.
Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up.
A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated. |
---|---|
AbstractList | Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.
Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA
DS
Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe.
Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up.
A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated. IntroductionAtrio‐esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose‐dependent esophageal temperature rise has been reported. In the TESO‐PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.MethodsConsecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2DS2Vasc Score 2) underwent first‐time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12‐pole temperature probe.ResultsMedian TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio‐esophageal fistula was reported on follow‐up.ConclusionA small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated. Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.INTRODUCTIONAtrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation (AF) ablation. Pulsed field ablation (PFA) uses electroporation as a new energy source for catheter ablation with promising periprocedural safety advantages over existing methods due to its unique myocardial tissue sensitivity. In preclinical animal studies, a dose-dependent esophageal temperature rise has been reported. In the TESO-PFA registry intraluminal esophageal temperature (TESO) changes in a clinical setting are evaluated.Consecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2 DS2 Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe.METHODSConsecutive symptomatic AF patients (62 years, 67% male, 61% paroxysmal AF, CHA2 DS2 Vasc Score 2) underwent first-time PFA and were prospectively enrolled into our registry. Eight pulse trains (2 kV/2.5 s, bipolar, biphasic, x4 basket/flower configuration each) were delivered to each pulmonary vein (PV). Two extra pulse trains per PV in flower configuration were added for wide antral circumferential ablation. Continuous intraluminal esophageal temperature (TESO) was monitored with a 12-pole temperature probe.Median TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up.RESULTSMedian TESO change was statistically significant and increased by 0.8 ± 0.6°C, p < .001. A TESO increase ≥ 1°C was observed in 10/43 (23%) patients. The highest TESO measured was 40.3°C. The largest TESO difference (∆TESO) was 3.7°C. All patients remained asymptomatic considering possible ETI. No atrio-esophageal fistula was reported on follow-up.A small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated.CONCLUSIONA small but significant intraluminal esophageal temperature rise can be observed in most patients during PFA. TESO rise over 40°C is rare. The clinical implications of the observed findings need to be further evaluated. |
Author | Hatahet, Sascha Heeger, Christian‐H. Feher, Marcel Kirstein, Bettina Samara, Omar Tilz, Roland R. Traub, Anna Subin, Behnam Kuck, Karl‐Heinz Phan, Huong‐Lan Mushfiq, Ilias Eitel, Charlotte Vogler, Julia |
Author_xml | – sequence: 1 givenname: Bettina orcidid: 0000-0002-6881-871X surname: Kirstein fullname: Kirstein, Bettina organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 2 givenname: Christian‐H. surname: Heeger fullname: Heeger, Christian‐H. organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany, German Center for Cardiovascular Research (DZHK) Partner Site Lübeck Lübeck Germany – sequence: 3 givenname: Julia orcidid: 0000-0002-8386-9750 surname: Vogler fullname: Vogler, Julia organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 4 givenname: Charlotte surname: Eitel fullname: Eitel, Charlotte organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 5 givenname: Marcel surname: Feher fullname: Feher, Marcel organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 6 givenname: Huong‐Lan orcidid: 0000-0002-6867-914X surname: Phan fullname: Phan, Huong‐Lan organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 7 givenname: Ilias surname: Mushfiq fullname: Mushfiq, Ilias organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 8 givenname: Anna surname: Traub fullname: Traub, Anna organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 9 givenname: Sascha surname: Hatahet fullname: Hatahet, Sascha organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 10 givenname: Omar surname: Samara fullname: Samara, Omar organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 11 givenname: Behnam orcidid: 0000-0002-4997-9841 surname: Subin fullname: Subin, Behnam organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 12 givenname: Karl‐Heinz surname: Kuck fullname: Kuck, Karl‐Heinz organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany – sequence: 13 givenname: Roland R. orcidid: 0000-0002-0122-7130 surname: Tilz fullname: Tilz, Roland R. organization: Department of Rhythmology University Heart Center Lübeck Lübeck Germany, German Center for Cardiovascular Research (DZHK) Partner Site Lübeck Lübeck Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37942843$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0E1LwzAYwPEginvRg19ACl700C1psjQ5ynA6GHjRc3maPtWOtqlJe_Dbm73oYRgCeQ6_BPKfkPPWtkjIDaMzFtZ8a3DGJNXyjIzZQtBYMZmeh5mKRcxVykdk4v2WUsYlXVySEU-1SJTgY7JaNx2YPrJl1A21xyIqK6yLCPIa-sq2UdhV2zuoh6ZqoY7Q2-4TPjCMPTYdOugHh1fkooRw_fp4Tsn76ult-RJvXp_Xy8dNbLhQfZwKjcBNARQMlakEJWUpOS9kDnmSJ1oZnkiWKmEKUVJIOKI2aYECFgnjgk_J_eHdztmvAX2fNZU3WNfQoh18liilKBdC60DvTujWDi58ISjNmNQ6TXbq9qiGvMEi61zVgPvOfgsF8HAAxlnvHZZ_hNFsVz8L9bN9_WDnJ9ZU_T5jCFjV_9z4AX9zheg |
CitedBy_id | crossref_primary_10_3390_jcm14062071 crossref_primary_10_1111_jce_16127 crossref_primary_10_3390_jcm13102980 crossref_primary_10_1007_s12170_024_00742_9 crossref_primary_10_1016_j_hroo_2024_08_002 crossref_primary_10_1111_jce_16454 crossref_primary_10_1080_17434440_2024_2447809 crossref_primary_10_1016_j_hroo_2024_05_002 crossref_primary_10_3390_jcm13175191 crossref_primary_10_1007_s00399_025_01071_z crossref_primary_10_1093_europace_euae134 crossref_primary_10_1093_europace_euaf035 |
Cites_doi | 10.1016/j.jacep.2021.02.014 10.1016/j.hrthm.2013.08.012 10.3389/fcvm.2023.1217745 10.1093/europace/euab090 10.1002/pros.22913 10.1161/CIRCEP.119.007781 10.1016/j.ijcha.2020.100576 10.1016/j.jacc.2019.04.021 10.1067/mtc.2001.118041 10.1007/s10439-005-8981-8 10.1111/jce.14980 10.1080/02656736.2020.1753828 10.1161/CIRCEP.119.008303 10.1093/europace/euac033 10.1007/978-3-642-05420-4_5 10.1161/CIRCEP.121.010168 10.1016/j.jacep.2018.04.005 10.1161/CIRCEP.120.008817 10.1007/s12181-017-0179-4 10.1093/eurheartj/ehaa612 10.1161/CIRCEP.116.004672 10.3389/fbioe.2020.552357 |
ContentType | Journal Article |
Copyright | 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC. 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC. – notice: 2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION NPM 7QP K9. 7X8 |
DOI | 10.1111/jce.16096 |
DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Biology |
EISSN | 1540-8167 |
EndPage | 85 |
ExternalDocumentID | 37942843 10_1111_jce_16096 |
Genre | Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 04C 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAYXX AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACDOS ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOJX ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFRAH AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMSDO BMXJE BPMNR BROTX BRXPI BY8 C45 CAG CITATION COF CS3 D-6 D-7 D-E D-F D-I DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS ECF ECT ECV EIHBH EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K VVN W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WVDHM WXI WXSBR XG1 ZGI ZXP ZZTAW ~IA ~WT AAMMB AEFGJ AGXDD AIDQK AIDYY NPM 7QP K9. 7X8 |
ID | FETCH-LOGICAL-c348t-749ea3cda0ac0676a866f633d6bab2b298c3261784cd4f0a23ee9c7de4a521343 |
ISSN | 1045-3873 1540-8167 |
IngestDate | Fri Jul 11 01:40:13 EDT 2025 Tue Aug 12 12:41:50 EDT 2025 Mon Jul 21 05:56:07 EDT 2025 Thu Apr 24 22:58:54 EDT 2025 Tue Jul 01 01:54:23 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | atrial fibrillation pulsed field ablation esophageal temperature esophageal thermal injury |
Language | English |
License | 2023 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c348t-749ea3cda0ac0676a866f633d6bab2b298c3261784cd4f0a23ee9c7de4a521343 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-6881-871X 0000-0002-8386-9750 0000-0002-6867-914X 0000-0002-0122-7130 0000-0002-4997-9841 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdf/10.1111/jce.16096 |
PMID | 37942843 |
PQID | 2911699729 |
PQPubID | 1086397 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2888034499 proquest_journals_2911699729 pubmed_primary_37942843 crossref_primary_10_1111_jce_16096 crossref_citationtrail_10_1111_jce_16096 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-01-00 2024-Jan 20240101 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of cardiovascular electrophysiology |
PublicationTitleAlternate | J Cardiovasc Electrophysiol |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_3_1 Dewhirst MW (e_1_2_8_19_1) 2003; 4954 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 Hong J (e_1_2_8_24_1) 2009; 2009 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 |
References_xml | – ident: e_1_2_8_25_1 doi: 10.1016/j.jacep.2021.02.014 – ident: e_1_2_8_20_1 doi: 10.1016/j.hrthm.2013.08.012 – ident: e_1_2_8_17_1 doi: 10.3389/fcvm.2023.1217745 – ident: e_1_2_8_26_1 doi: 10.1093/europace/euab090 – ident: e_1_2_8_5_1 doi: 10.1002/pros.22913 – ident: e_1_2_8_12_1 doi: 10.1161/CIRCEP.119.007781 – ident: e_1_2_8_18_1 doi: 10.1016/j.ijcha.2020.100576 – ident: e_1_2_8_14_1 doi: 10.1016/j.jacc.2019.04.021 – ident: e_1_2_8_3_1 doi: 10.1067/mtc.2001.118041 – ident: e_1_2_8_6_1 doi: 10.1007/s10439-005-8981-8 – ident: e_1_2_8_10_1 doi: 10.1111/jce.14980 – ident: e_1_2_8_21_1 doi: 10.1080/02656736.2020.1753828 – ident: e_1_2_8_13_1 doi: 10.1161/CIRCEP.119.008303 – ident: e_1_2_8_22_1 doi: 10.1093/europace/euac033 – ident: e_1_2_8_7_1 doi: 10.1007/978-3-642-05420-4_5 – ident: e_1_2_8_15_1 doi: 10.1161/CIRCEP.121.010168 – volume: 4954 start-page: 37 year: 2003 ident: e_1_2_8_19_1 article-title: Thermal dose requirement for tissue effect: experimental and clinical findings publication-title: Proc SPIE Int Soc Opt Eng – ident: e_1_2_8_11_1 doi: 10.1016/j.jacep.2018.04.005 – ident: e_1_2_8_4_1 doi: 10.1161/CIRCEP.120.008817 – ident: e_1_2_8_16_1 doi: 10.1007/s12181-017-0179-4 – volume: 2009 start-page: 3381 year: 2009 ident: e_1_2_8_24_1 article-title: Cardiacablation via electroporation publication-title: Conf Proc IEEE Eng Med Biol Soc – ident: e_1_2_8_2_1 doi: 10.1093/eurheartj/ehaa612 – ident: e_1_2_8_23_1 – ident: e_1_2_8_8_1 doi: 10.1161/CIRCEP.116.004672 – ident: e_1_2_8_9_1 doi: 10.3389/fbioe.2020.552357 |
SSID | ssj0013605 |
Score | 2.5100162 |
Snippet | Atrio-esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial fibrillation... IntroductionAtrio‐esophageal fistula after esophageal thermal injury (ETI) is one of the most devastating complications of available energy sources for atrial... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 78 |
SubjectTerms | Ablation Electroporation Esophagus Fistula Fistulae Statistical analysis Thermal injury |
Title | Impact of pulsed field ablation on intraluminal esophageal temperature |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37942843 https://www.proquest.com/docview/2911699729 https://www.proquest.com/docview/2888034499 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKJtBe0Nj4GGzIIISQpkxZ7KTxYztaFdgGDy3qW3RxnIHUJRMkD_CH8PfuHDtOi7rxIVWRlbpO5fv57uz87o6QV1lfCFw14CFWAo9nPveEkKEO8MlyHvbR4uto5LPzaDLj7-fhvNf7tcRaqqv0SP5cG1fyP1LFeyhXHSX7D5J1g-INbKN88YoSxutfyfidC3G8qtHEZYcNH-0Q0oV1BDWNUR9l1KZ0l9I1C1CBaIK5Qn_Z5FO-wT-Vq0xVWy-nOQlZOYr_8BUdSFsyc6g0jboj_3yxKsRRKiZo59RFxwj-XF7YUEQdqO1-OEJHeOHYAGXLRrKnEwH_7XTizzpwSfeid6lT_Rp9p6w-5r4XH5uKHa3CNvlNVoBptK8pBtTa8fA2CyGVPlcTa7Jwn39MxrPT02Q6mk_vkM0Atx-oPzcHw7fDcfd-ykTcur9sc1Y1HLF26FVP54btS-PGTLfJfStfOjBgekB6qtghu4MCqvLyB31NPzn57pC7w7Z178xSMHbJ2ICOljk1oKMN6GgLOoqfZdDRDnR0CXQPyWw8mp5MPFuMw5OMx5XX50IBkxn4INHDiSCOojxiLItSSIM0ELFkOrt_zGXGcx8CppSQ_UxxCHXWQPaIbBRloZ4QGjI_hlwASKmryoeg8mOOLYhwcyBA7JE37cQl0maq1wVTFonbsUqVNHO8R166rlcmPcu6Tvvt7Cd29X5PArTykY4ax8e9cF-jbtUvzKBQZY19YrRujHOBfR4bqbmnMDRk6Nqxp7cP_oxsdctin2xU32p1gG5slT63mLoGe8iibg |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+pulsed+field+ablation+on+intraluminal+esophageal+temperature&rft.jtitle=Journal+of+cardiovascular+electrophysiology&rft.au=Kirstein%2C+Bettina&rft.au=Christian%E2%80%90H+Heeger&rft.au=Vogler%2C+Julia&rft.au=Eitel%2C+Charlotte&rft.date=2024-01-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1045-3873&rft.eissn=1540-8167&rft.volume=35&rft.issue=1&rft.spage=78&rft.epage=85&rft_id=info:doi/10.1111%2Fjce.16096&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-3873&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-3873&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-3873&client=summon |